India Metronidazole Market to grow at a steady rate During the Forecast Period
Growing prevalence of
diseases is expected to drive the growth of India metronidazole market.
According
to TechSci Research report, “India
Metronidazole Market By Type of Process (Glyoxal Process, Ethidene Diamine
Process, Others), By Source (In-house v/s Contract Manufacturing
Organizations), By Route of Administration (Oral v/s Intravenous), By Form
(Tablet, Capsule, Injection, Others), By Distribution Channel (Online v/s
Offline), By Product Type (Prescription v/s OTC), By Application
(Dracunculiasis, Giardiasis, Trichomoniasis, Amebiasis, Bacterial Vaginosis,
Others), By Company, By Region, Forecast & Opportunities, FY2026”, the India metronidazole market is expected to grow at a steady
rate during the forecast period on account of the extensive use of the drug in
treatment of Dracunculiasis, Giardiasis, Trichomoniasis, Amebiasis, among
others. Additionally, the antibiotic is present in WHO’s list of essential
drugs thereby increasing its demand and use. This in turn is expected to
positively influence the market growth over the next few years. Furthermore,
metronidazole serves as an alternative to vancomycin in the treatment of
clostridium difficile colitis. However, side effects such as loss of appetite,
headache, nausea, dizziness, blurred vision, drowsiness, fever among others are
observed due to the intake of metronidazole thereby hampering the market growth
through FY2026. Also, the drug is not safe for use in the early stages of
pregnancy. Moreover, allergic reactions and sometimes seizures are also
observed in certain cases due to consumption of metronidazole. Besides, the drug
is not effective against viral infections such as common cold, flu, among
others.
Browse XX market data Tables
and XX Figures spread through XXX
Pages and an in-depth TOC on" India Metronidazole
Market"
https://www.techsciresearch.com/report/india-metronidazole-market/7196.html
The India metronidazole market is segmented based on type of process, source,
form, route of administration, distribution channel, product type, application,
company and region. Based on source, the market can be split into in-house and
contract manufacturing organizations. The in-house segment is expected to
dominate the market on account of the presence of well-established big pharma
giants and local players operating in the market. Additionally, the launch of
schemes such as production linked incentive scheme for manufacturing of APIs
locally in India will boost the status of domestic players thereby driving the
segmental growth. Based on form, the market can be categorized into tablets,
capsule, injection and others. The tablets segment is expected to dominate the
market on account of the benefits such as easy availability, low cost, ability
to split into two in case a low dose has to be administered, durability, long
lasting effect, among others. Additionally, a single API can accommodate large
dose of API as compared to a capsule. Based on distribution channel, the market
can be split into online and offline. The offline segment is expected to dominate
the market on account of the well established network of pharmacies in the
country. The online segment is expected to register significant growth during
forecast period due to the emergence of several online pharmacies and
e-commerce platforms.
Unichem Laboratories Ltd., Aarey Drugs & Pharmaceuticals Ltd., Aarti
Drugs Ltd., Lupin Limited, Abbott India Ltd., Atom Pharmaceuticals Pvt. Ltd.,
GlaxoSmithKline Pharmaceuticals Ltd., Aristo Pharmaceuticals Pvt. Ltd., Geno
Pharmaceuticals Private Limited, Torrent Pharmaceuticals Ltd. and others are some
of the leading players operating in India Metronidazole market. Companies operating in the market are using organic
strategies such as product launches, mergers and acquisitions and research
collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7196
Customers can also request for 10% free customization on
this report.
“India metronidazole market is expected
to witness growth during the forecast period on account of the growing focus of
the government in making the country self-sufficient with respect to API
manufacturing and drug development. With respect to this the government of
India has launched few schemes and policies such as production linked incentive
scheme, scheme for establishment of bulk drug parks, China plus one strategy,
among others.” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Metronidazole Market By Type of Process
(Glyoxal Process, Ethidene Diamine Process, Others), By Source (In-house v/s
Contract Manufacturing Organizations), By Route of Administration (Oral v/s
Intravenous), By Form (Tablet, Capsule, Injection, Others), By Distribution
Channel (Online v/s Offline), By Product Type (Prescription v/s OTC), By
Application (Dracunculiasis, Giardiasis, Trichomoniasis, Amebiasis, Bacterial
Vaginosis, Others), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India metronidazole
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India metronidazole market.
Contact
Mr. Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]